CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XL. QUANTITATIVE SEPARATION AND DETERMINATION OF THE PROTEIN COMPONENTS IN SMALL AMOUNTS OF NORMAL HUMAN PLASMA

^{University Laboratory of Physical Chemistry Related to Medicine and Public Health, Harvard University, Boston}

^{Department of Dermatology, Harvard Medical School, Boston}

Fellow of the Suomen Kulturri Rabasto, Helsinki. Present address: Department of Serobacteriology, University of Helsinski, Helsinki, Finland.

Public Health Research Fellow of the National Institutes of Health.

Research Fellow of the Life Insurance Medical Research Fund. Present address: Massachusetts General Hospital, Boston, Mass.

This work was supported by grants from the National Institutes of Health, from industry, funds at the disposal of Harvard University, and by aid from the Harry Helfman Pemphigus Research Fund, the Milton Fund, and other sources. This paper is No. 91 in the series “Studies on the Plasma Proteins” from blood collected by the American Red Cross, on products developed by the University Laboratory of Physical Chemistry Related to Medicine and Public Health, Harvard University.

Find articles by Lever, W. in: PubMed | Google Scholar

^{University Laboratory of Physical Chemistry Related to Medicine and Public Health, Harvard University, Boston}

^{Department of Dermatology, Harvard Medical School, Boston}

Fellow of the Suomen Kulturri Rabasto, Helsinki. Present address: Department of Serobacteriology, University of Helsinski, Helsinki, Finland.

Public Health Research Fellow of the National Institutes of Health.

Research Fellow of the Life Insurance Medical Research Fund. Present address: Massachusetts General Hospital, Boston, Mass.

This work was supported by grants from the National Institutes of Health, from industry, funds at the disposal of Harvard University, and by aid from the Harry Helfman Pemphigus Research Fund, the Milton Fund, and other sources. This paper is No. 91 in the series “Studies on the Plasma Proteins” from blood collected by the American Red Cross, on products developed by the University Laboratory of Physical Chemistry Related to Medicine and Public Health, Harvard University.

Find articles by Gurd, F. in: PubMed | Google Scholar

^{University Laboratory of Physical Chemistry Related to Medicine and Public Health, Harvard University, Boston}

^{Department of Dermatology, Harvard Medical School, Boston}

Fellow of the Suomen Kulturri Rabasto, Helsinki. Present address: Department of Serobacteriology, University of Helsinski, Helsinki, Finland.

Public Health Research Fellow of the National Institutes of Health.

Research Fellow of the Life Insurance Medical Research Fund. Present address: Massachusetts General Hospital, Boston, Mass.

This work was supported by grants from the National Institutes of Health, from industry, funds at the disposal of Harvard University, and by aid from the Harry Helfman Pemphigus Research Fund, the Milton Fund, and other sources. This paper is No. 91 in the series “Studies on the Plasma Proteins” from blood collected by the American Red Cross, on products developed by the University Laboratory of Physical Chemistry Related to Medicine and Public Health, Harvard University.

Find articles by Uroma, E. in: PubMed | Google Scholar

^{University Laboratory of Physical Chemistry Related to Medicine and Public Health, Harvard University, Boston}

^{Department of Dermatology, Harvard Medical School, Boston}

Fellow of the Suomen Kulturri Rabasto, Helsinki. Present address: Department of Serobacteriology, University of Helsinski, Helsinki, Finland.

Public Health Research Fellow of the National Institutes of Health.

Research Fellow of the Life Insurance Medical Research Fund. Present address: Massachusetts General Hospital, Boston, Mass.

This work was supported by grants from the National Institutes of Health, from industry, funds at the disposal of Harvard University, and by aid from the Harry Helfman Pemphigus Research Fund, the Milton Fund, and other sources. This paper is No. 91 in the series “Studies on the Plasma Proteins” from blood collected by the American Red Cross, on products developed by the University Laboratory of Physical Chemistry Related to Medicine and Public Health, Harvard University.

Find articles by Brown, R. in: PubMed | Google Scholar

^{University Laboratory of Physical Chemistry Related to Medicine and Public Health, Harvard University, Boston}

^{Department of Dermatology, Harvard Medical School, Boston}

Fellow of the Suomen Kulturri Rabasto, Helsinki. Present address: Department of Serobacteriology, University of Helsinski, Helsinki, Finland.

Public Health Research Fellow of the National Institutes of Health.

Research Fellow of the Life Insurance Medical Research Fund. Present address: Massachusetts General Hospital, Boston, Mass.

This work was supported by grants from the National Institutes of Health, from industry, funds at the disposal of Harvard University, and by aid from the Harry Helfman Pemphigus Research Fund, the Milton Fund, and other sources. This paper is No. 91 in the series “Studies on the Plasma Proteins” from blood collected by the American Red Cross, on products developed by the University Laboratory of Physical Chemistry Related to Medicine and Public Health, Harvard University.

Find articles by Barnes, B. in: PubMed | Google Scholar

^{University Laboratory of Physical Chemistry Related to Medicine and Public Health, Harvard University, Boston}

^{Department of Dermatology, Harvard Medical School, Boston}

Fellow of the Suomen Kulturri Rabasto, Helsinki. Present address: Department of Serobacteriology, University of Helsinski, Helsinki, Finland.

Public Health Research Fellow of the National Institutes of Health.

Research Fellow of the Life Insurance Medical Research Fund. Present address: Massachusetts General Hospital, Boston, Mass.

This work was supported by grants from the National Institutes of Health, from industry, funds at the disposal of Harvard University, and by aid from the Harry Helfman Pemphigus Research Fund, the Milton Fund, and other sources. This paper is No. 91 in the series “Studies on the Plasma Proteins” from blood collected by the American Red Cross, on products developed by the University Laboratory of Physical Chemistry Related to Medicine and Public Health, Harvard University.

Find articles by Schmid, K. in: PubMed | Google Scholar

^{University Laboratory of Physical Chemistry Related to Medicine and Public Health, Harvard University, Boston}

^{Department of Dermatology, Harvard Medical School, Boston}

Fellow of the Suomen Kulturri Rabasto, Helsinki. Present address: Department of Serobacteriology, University of Helsinski, Helsinki, Finland.

Public Health Research Fellow of the National Institutes of Health.

Research Fellow of the Life Insurance Medical Research Fund. Present address: Massachusetts General Hospital, Boston, Mass.

This work was supported by grants from the National Institutes of Health, from industry, funds at the disposal of Harvard University, and by aid from the Harry Helfman Pemphigus Research Fund, the Milton Fund, and other sources. This paper is No. 91 in the series “Studies on the Plasma Proteins” from blood collected by the American Red Cross, on products developed by the University Laboratory of Physical Chemistry Related to Medicine and Public Health, Harvard University.

Find articles by Schultz, E. in: PubMed | Google Scholar